Germany
Japan
United Kingdom
China
USD 399.00
In Stock
Fluorescent Protein Antibodies
View as table Download
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
Rabbit polyclonal CD38 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD38 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 241-270 amino acids from the C-terminal region of human CD38. |
Rabbit polyclonal Neprilysin Antibody (C-term)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This Neprilysin antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 506-534 amino acids from the C-terminal region of human Neprilysin. |
Rat Anti-Human/Mouse CD45R (B220) Purified (100 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rabbit polyclonal ITGAX Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ITGAX antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1119-1145 amino acids from the C-terminal region of human ITGAX. |
USD 485.00
2 Weeks
Colorectal Carcinoma/CD3 (Bispecific) mouse monoclonal antibody, clone BS-1, Aff - Purified
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 160.00
In Stock
Rat Anti-Human/Mouse CD49f (Integrin alpha 6) Purified (50 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Mouse Anti-Human CD45RA Purified (100 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit polyclonal FLT3 (CD135) Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This FLT3 (CD135) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 33-64 amino acids from the N-terminal region of human FLT3 (CD135). |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Alexa Fluor 488 |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Alexa Fluor 647 |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Biotin |
CD38 mouse monoclonal antibody, clone HB7
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse anti CD61 Monoclonal Antibody
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Reactivities
- Human
Applications
- FC
Filter by
Category
Target Symbol
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
Assay Types
Families
- Transmembrane (278)
- Druggable Genome (218)
- ES Cell Differentiation/IPS (121)
- Phosphatase (45)
- Cancer stem cells (37)
- Protease (22)
- Adult stem cells (21)
- Embryonic stem cells (21)
- Secreted Protein (18)
- Induced pluripotent stem cells (16)
- Stem cell relevant signaling - DSL/Notch pathway (16)
- Protein Kinase (1)
Pathways
- Hematopoietic cell lineage (179)
- Fc gamma R-mediated phagocytosis (80)
- Primary immunodeficiency (76)
- Cell adhesion molecules (CAMs) (52)
- T cell receptor signaling pathway (50)
- Systemic lupus erythematosus (35)
- B cell receptor signaling pathway (26)
- Alzheimer's disease (22)
- Renin-angiotensin system (22)
- Cytokine-cytokine receptor interaction (21)
- Apoptosis (20)
- Jak-STAT signaling pathway (20)
- Natural killer cell mediated cytotoxicity (20)
- ECM-receptor interaction (18)
- Calcium signaling pathway (16)
- Metabolic pathways (16)
- Nicotinate and nicotinamide metabolism (16)
- Lysosome (10)
- Antigen processing and presentation (5)
- Graft-versus-host disease (5)
- Regulation of actin cytoskeleton (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Dilated cardiomyopathy (2)
- Focal adhesion (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Pathways in cancer (2)
- Acute myeloid leukemia (1)
- Leukocyte transendothelial migration (1)
- Small cell lung cancer (1)